CLINICAL_TRIALS
trial_result
· 2020-10-01
Clinical Trial Update: PH 2 ADI-PEG 20 Acute Myeloid Leukemia [Phase 2]
Summary
Phase 2 clinical trial update for ADI-PEG 20 in Acute Myeloid Leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Polaris Group | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED